Sensei Biotherapeutics (FTH) – Analysts’ Recent Ratings Changes
Several analysts have recently updated their ratings and price targets for Sensei Biotherapeutics (NASDAQ: FTH): 7/31/2026 – Sensei Biotherapeutics is now covered by Raymond James Financial, Inc.. They set an “outperform” rating and a $56.00 price target on the stock. 7/28/2026 – Sensei Biotherapeutics is now covered by Oppenheimer Holdings, Inc.. They set an “outperform” […]
3 Aug 11:26 · The Cerbat Gem